1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Clario Acquires NeuroRx

M&A Deal Summary

Clario Acquires NeuroRx

On March 17, 2025, Clario acquired life science company NeuroRx

Acquisition Highlights
  • This is Clario’s 4th transaction in the Life Science sector.
  • This is Clario’s 10th transaction in the United States.

M&A Deal Summary
Date 2025-03-17
Target NeuroRx
Sector Life Science
Buyer(s) Clario
Deal Type Add-on Acquisition

Target

NeuroRx

United States
NeuroRx is an imaging provider with unparalleled expertise in diseases impacting the Central Nervous System ("CNS"), such as multiple sclerosis, Huntington's, Parkinson's, Alzheimer's, and other rare neurological diseases.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Clario

Philadelphia, Pennsylvania, United States
Category Company
Founded 1972
Sector Medical Products
Employees3,800
DESCRIPTION

Clario offers a compelling combination of technology, services, and clinical expertise, helping customers to deliver successful clinical trial outcomes by ensuring high-quality data capture, reduced costs, and shortened study timelines. Clario was founded in 1972 and is based in Philadelphia, Pennsylvania.

DEAL STATS #
Overall 12 of 12
Sector: Life Science M&A 4 of 4
Type: Add-on Acquisition M&A Deals 8 of 8
Country: United States M&A 10 of 10
Year: 2025 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-03-10 WCG - eCOA Business

Princeton, New Jersey, United States

WCG's eCOA Business offers robust, full-service clinical expertise and specialized functionality, particularly in neurology, psychiatry, neuropathic pain, and rare diseases. WCG's eCOA Business is based in Princeton, New Jersey.

Buy -
Mergr

Solution for

Product

Company

Legal